J9200 is the authoritative medical code for Injection, floxuridine, 500 mg. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, floxuridine, 500 mg (HCPCS Level II J9200), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, floxuridine, 500 mg is a HCPCS Level II code J9200 for a Medicare-covered supply, service, or procedure. Short description: Floxuridine injection.
Codes in This Family (40)
Official HCPCS Level II classifications in the same code family as J9200, with their registry titles.
- J9201 — Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
- J9202 — Goserelin acetate implant, per 3.6 mg
- J9203 — Injection, gemtuzumab ozogamicin, 0.1 mg
- J9204 — Injection, mogamulizumab-kpkc, 1 mg
- J9205 — Injection, irinotecan liposome, 1 mg
- J9206 — Injection, irinotecan, 20 mg
- J9207 — Injection, ixabepilone, 1 mg
- J9208 — Injection, ifosfamide, 1 gram
- J9209 — Injection, mesna, 200 mg
- J9210 — Injection, emapalumab-lzsg, 1 mg
- J9211 — Injection, idarubicin hydrochloride, 5 mg
- J9212 — Injection, interferon alfacon-1, recombinant, 1 microgram
- J9213 — Injection, interferon, alfa-2a, recombinant, 3 million units
- J9214 — Injection, interferon, alfa-2b, recombinant, 1 million units
- J9215 — Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
- J9216 — Injection, interferon, gamma 1-b, 3 million units
- J9217 — Leuprolide acetate (for depot suspension), 7.5 mg
- J9218 — Leuprolide acetate, per 1 mg
- J9219 — Leuprolide acetate implant, 65 mg
- J9220 — Injection, indigotindisulfonate sodium, 1 mg
- J9223 — Injection, lurbinectedin, 0.1 mg
- J9225 — Histrelin implant (vantas), 50 mg
- J9226 — Histrelin implant (supprelin la), 50 mg
- J9227 — Injection, isatuximab-irfc, 10 mg
- J9228 — Injection, ipilimumab, 1 mg
- J9229 — Injection, inotuzumab ozogamicin, 0.1 mg
- J9230 — Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
- J9232 — Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg
- J9245 — Injection, melphalan hydrochloride, not otherwise specified, 50 mg
- J9246 — Injection, melphalan (evomela), 1 mg
- J9247 — Injection, melphalan flufenamide, 1mg
- J9248 — Injection, melphalan (hepzato), 1 mg
- J9249 — Injection, melphalan (apotex), 1 mg
- J9250 — Methotrexate sodium, 5 mg
- J9255 — Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg
- J9256 — Injection, nipocalimab-aahu, 3 mg
- J9258 — Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
- J9259 — Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
- J9260 — Injection, methotrexate sodium, 50 mg
- J9261 — Injection, nelarabine, 50 mg
Related Codes & Numerical Sequence (Crawl Map)
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:
HCPCS Code J9196
Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
HCPCS Code J9201
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg